Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8124582 Treatment of diabetes

Patent 8124582 was granted and assigned to Fibrogen, Inc. on February, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Todd W. Seeley0

Ingrid Langsetmo Parobok0

Stephen J. Klaus0

Volkmar Guenzler-Pukall0

Date of Patent

February 28, 2012

0

Patent Application Number

107297040

Date Filed

December 4, 2003

0

Patent Citations Received

US Patent 11857543 Compositions and methods for treating anemia

0

US Patent 11883386 Prolyl hydroxylase inhibitors and methods of use

0

US Patent 11713298 Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid

0

Patent Primary Examiner

Christopher R. Tate

0

Patent abstract

The present invention relates to methods and compounds for regulating glucose metabolism, achieving glucose homeostasis, and decreasing blood glucose levels. Methods and compounds for treating or preventing diabetes, hyperglycemia, and disorders and conditions associated with altered or impaired glucose metabolism are also provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8124582 Treatment of diabetes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool